文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Effective treatment with imatinib for acute B-lymphoblastic leukaemia with EBF1-PDGFRB fusion.

作者信息

Horiuchi Mirei, Yoshida Masahiro, Yamasaki Kai, Sakagami Ryoko, Aoyama Takane, Tatsumi Naoko, Tsutsumi Minako, Nakaya Yosuke, Fuseya Hoyuri, Yoshimura Takuro, Hayashi Yoshiki, Nakao Takafumi, Yamane Takahisa

机构信息

Department of Hematology, Osaka City General Hospital, Osaka, Japan.

Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan.

出版信息

Ann Hematol. 2021 May;100(5):1329-1331. doi: 10.1007/s00277-020-04332-8. Epub 2020 Nov 5.

DOI:10.1007/s00277-020-04332-8
PMID:33150465
Abstract
摘要

相似文献

[1]
Effective treatment with imatinib for acute B-lymphoblastic leukaemia with EBF1-PDGFRB fusion.

Ann Hematol. 2021-5

[2]
Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with fusion transcript.

Leuk Lymphoma. 2020-2

[3]
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.

Blood. 2016-2-12

[4]
B-Cell Precursor-Acute Lymphoblastic Leukemia With EBF1-PDGFRB Fusion Treated With Hematopoietic Stem Cell Transplantation and Imatinib: A Case Report and Literature Review.

J Pediatr Hematol Oncol. 2021-1

[5]
[Acute lymphoblastic leukemia with EBF1-PDGFRB fusion gene: two cases report and literature review].

Zhonghua Xue Ye Xue Za Zhi. 2023-1-14

[6]
Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.

Acta Haematol. 2019-2-6

[7]
Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion.

Haematologica. 2013-11

[8]
Early diagnosis of EBF1-PDGFRB-positive acute lymphoblastic leukemia.

Pediatr Int. 2022-1

[9]
Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.

Int J Hematol. 2021-2

[10]
ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children.

Br J Haematol. 2014-3-15

引用本文的文献

[1]
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain.

Blood. 2024-5-23

[2]
The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and sensitivity to TKI in ph-like ALL.

J Cell Mol Med. 2024-2

[3]
[Acute lymphoblastic leukemia with EBF1-PDGFRB fusion gene: two cases report and literature review].

Zhonghua Xue Ye Xue Za Zhi. 2023-1-14

[4]
Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.

Genes (Basel). 2021-5-1

[5]
Interstitial Deletions Generating Fusion Genes.

Cancer Genomics Proteomics. 2021

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索